Among these, six cancers had additional genetic alterations: BRAF fusions (n = 2), and one each with RET fusion plus BRCA2 loss of function mutation, IDH1 mutation, RAF1 fusion, and EML4-NTRK3 fusion. This evidence concerns the gene BRCA2 and cancer.